Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety, efficacy, and pharmacokinetics of leuprolide mesylate in subjects with advanced prostate cancer has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostatic Neoplasms

Drugs mentioned

• Leuprolide mesylate (leuprolide mesylate)

Snippet

Sponsor: Foresee Pharmaceuticals Co., Ltd. | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2018-04-13